top of page
EVENT HIGHLIGHTS

Anchored in Hong Kong, Connecting the Greater Bay Area - From GBA to Global Health Summit

BY:

Dr. Roy Lau

Apr 11, 2025

  • 微信图片_20260414172211_190_280
  • 微信图片_20260414172239_191_280


The global healthcare industry has become an integral part of China's new-quality productive forces. Particularly, the Guangdong-Hong Kong-Macao Greater Bay Area (GBA) is emerging as a global medical hub, boasting unique strengths in research, clinical practice, services, facilities, and outstanding talent.

 

On 12th February 2025, the New Frontier Group, a local enterprise aiming to build the leading healthcare system that deliver world class patient care, signed a strategic cooperation agreement with the Hong Kong Investment Corporation Limited (HKIC), which is wholly owned by the Hong Kong Government for consolidating the management of the investment activities of the “Hong Kong Growth Portfolio”, “Greater Bay Area Investment Fund”, “Strategic Tech Fund”, and the newly established “Co-Investment Fund”. The parties jointly held a strategic partnership kick-off ceremony titled “Anchored in Hong Kong, Connecting the Greater Bay Area”. The goal of the strategic partnership is to better utilise the leading medical research, professional medical system and efficient international networks in Hong Kong, and hence to facilitate the cross-border medical research and clinical applications.

 

Following the strategic partnership kick-off ceremony, the New Frontier Group hosted the first "From GBA to Global Health Summit", which was attended by over 300 domestic and international experts, scholars, and industry guests. Distinguished guest speakers, including Dr KO Wing-man, Executive Council Non-official member; Prof. Nancy IP, President of the Hong Kong University of Science and Technology; Prof. YUEN Kwok-yung, the Chair in the Department of Microbiology of the University of Hong Kong; and Prof. HE Jianxing, Director of National Respiratory Medicine Center, delivered keynote speeches and participated in panel discussions focusing on the latest developments in clinical research and treatment innovation, life sciences, the transformative role of AI in healthcare, and new trends in cross-border medical and treatment.

 

A Speech on cancer care by Prof. Tony Mok

 

The strategic partnership kick-off ceremony. (From left): Mr. Antony LEUNG, Co-founder and Chairman of New Frontier Group; Ms. Clara CHAN, CEO of HKIC; Mr. Paul CHAN, the Financial Secretary of the Hong Kong SAR Government; Mr. Carl WU, Co-founder and CEO of New Frontier Group and CEO of United Family Healthcare.

 

The opening speech by Ms. Clara CHAN, CEO of HKIC

POPULAR STORY

Uncovering the Tricks of the Silent Thief of Sight

Dr. Roy Lau

Dec 19, 2024

What’s New in Coronary Artery Disease?

Dr. Roy Lau

Aug 20, 2024

Challenges and Strategies for Managing CHB Patients with Co-morbidities

Dr. Roy Lau

Jun 21, 2024

Decoding the Paradox on Impact of Obesity on Cognitive Functioning

Dr. Roy Lau

Jun 20, 2024

Gain Without Pain – Revisiting the Pain Management in Rheumatoid Arthritis

Dr. Roy Lau

Oct 22, 2024

Uncovering the Art of Perfect Matching – A Review on Precision Oncology

Dr. Roy Lau

Feb 17, 2025

The Earlier The Better: The New Frontiers of Lipid Research for Cardiovascular Disease Prevention

Dr. Feng Xue

Feb 11, 2026

What Should We Know About Anxiety Disorder?

Dr. Roy Lau

Apr 11, 2025

Rheumatology in 2025: Breakthroughs, Technologies, and the Future of Care

Dr. Feng Xue

Oct 24, 2025

Rare Genomic Targets in NSCLC: 2025 Breakthroughs in Precision Therapy and Future Directions

Dr. Feng Xue

Dec 19, 2025

Breaking the Pathologic Combo of CVD and T2DM – Now and Then

Dr. Roy Lau

Aug 14, 2025

No More Itch – Uncovering Urticaria and Its Clinical Management

Dr. Roy Lau

Jun 13, 2025

bottom of page